The Indiana University School of Medicine conducts a broad range of basic, translational and clinical research in order to:
- Improve health
- Prevent disease
- Better train future physicians
- Provide a foundation for Indiana's life sciences economy
The school holds more than $240 million in research grants and contracts, including more than $100 million in awards from the National Institutes of Health.
It is home to the Indiana Clinical and Translational Sciences Institute, a statewide academic, business and government collaboration to move the discoveries of basic science into better health care for the people of Indiana and beyond. It also hosts federally designated centers of excellence at both pediatric and adult levels in:
- Women's health
- Kidney disease
- Alzheimer's disease and related disorders
- Alcohol research
- Sexually transmitted disease
The Regenstrief Institute, an international leader in medical informatics, is affiliated with the IU School of Medicine.
Currently, the IU School of Medicine is working to aggressively double its research enterprise by adding nearly 400 new investigators and to construct additional highly-advanced research facilities to accommodate them.
The IU School of Medicine includes the 35-year-old Krannert Institute of Cardiology, respected worldwide for developing innovative approaches to diagnosing and treating the most difficult cardiac conditions.
Plus, the Indiana University Melvin and Bren Simon Cancer Center is the only Indiana-based cancer center providing patient care with a National Cancer Institute designation.
IU Health's partnership with the IU School of Medicine allows new treatment options to move from the laboratory bench to the patient's bedside at a noteworthy rate.